www.fdanews.com/articles/184602-fda-clears-perspectum-diagnostics-liver-scanning-device
FDA Clears Perspectum Diagnostics Liver Scanning Device
November 29, 2017
The FDA granted marketing clearance to Perspectum Diagnostics’ LiverMultiScan a post-processing software device for magnetic resonance imaging of the liver, delivered through a cloud-based service.
The liver characterization procedure is non-invasive and does not require contrast agents. The clearance means the technology can now be used on a wider range of scanners, including compatible Siemens and Philips MR systems.
LiverMultiScan is CE marked in Europe.